Monitoring Agency Report for the quarter ended March 31, 2025 is attached.
WELSPLSOL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
CARE Ratings Limited, acting as Monitoring Agency, has submitted its report on the use of proceeds from Welspun Specialty Solutions' Rights Issue of Rs. 349.85 crore (open March 10–19, 2025). During the quarter, Rs. 284 crore was fully used to repay/prepay borrowings as planned, and Rs. 3.90 crore of the Rs. 63.56 crore earmarked for General Corporate Purposes was spent on interest payments (ICD interest, WCL interest, Yes Bank term loan interest). The remaining Rs. 61.95 crore (including Rs. 2.29 crore for issue expenses) is parked in fixed deposits with Yes Bank earning 6.25%–7.75% and in an escrow account. There is no deviation from the stated objects and no delay in implementation, with the borrowings repayment already completed.
This is a routine compliance update confirming that the company is using Rights Issue funds exactly as promised to shareholders, with full debt repayment already done. For investors, it signals disciplined capital allocation and no misuse of funds, though the stock-price impact is likely neutral since no new business news is disclosed.